Tower Research Capital LLC (Trc) Eledon Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,944 shares of ELDN stock, worth $34,874. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,944
Previous 1,532
418.54%
Holding current value
$34,874
Previous $3,000
966.67%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ELDN
# of Institutions
77Shares Held
37.2MCall Options Held
17KPut Options Held
2.7K-
Bvf Inc San Francisco, CA6.29MShares$27.6 Million0.96% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$15.7 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$12.7 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.55MShares$11.2 Million2.15% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$10.2 Million0.93% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $60.4M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...